Laurent DECORY
Curevac partners with Bayer Pharma to boost mRNA Covid vaccine
After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer...
top of page
For Pharma, Biotech, MedTech.
Commercialization: Implemented
Search
Laurent DECORY
Jan 4, 20211 min read
Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
Oxford University/AstraZeneca Covid-19 vaccine, based on viral vector technology and now approved by UK authorities, will be vital for...
1 view0 comments
Laurent DECORY
Dec 22, 20201 min read
mRNA-based vaccines: a story of immigration, science and resilience
Behind the success of BioNTech Pfizer and Moderna mRNA-based Covid vaccines, lays the story of 4 immigrants, Katalin Kariko, Ugur Sahin,...
2 views0 comments
Laurent DECORY
Dec 16, 20201 min read
Moderna Covid-19 vaccine: 94% efficacy with easier storage
Following Pfizer-BioNTech 90% efficacy announcement, Moderna data show 94% efficacy against Covid-19, while allowing easier storage: long...
0 views0 comments
Laurent DECORY
Dec 13, 20201 min read
mRNA-based treatments turn body cells into drug factories
mRNA treatments are about to revolutionize treatments of infectious and cancer diseases. After Covid-19 vaccines, next step will be...
0 views0 comments
Laurent DECORY
Dec 12, 20201 min read
Taking necessary time to approve Covid19 vaccines
With growing anti-vax sentiment, and regardless of the political agenda, it is critical that the industry and regulatory authorities take...
0 views0 comments
bottom of page